Journal of Vaccine Research 2024, Vol.14, No.2, 54-64 http://medscipublisher.com/index.php/jvr 62 antibiotics and preventing the spread of resistant strains (Jansen et al., 2021). Economic evaluations of vaccines should be expanded to capture their benefits in reducing AMR, which can incentivize the development and introduction of the right vaccines (Jit and Cooper, 2020). Additionally, international collaborations among health workers, researchers, and policymakers are essential to build surveillance and control strategies to combat antibiotic resistance effectively (Kumar, 2018). Finally, public health campaigns should be implemented to raise awareness about the importance of vaccination in preventing infections and reducing AMR (Micoli et al., 2021). 9 Concluding Remarks The research papers collectively underscore the significant role that vaccines play in mitigating antimicrobial resistance (AMR). Vaccines reduce the incidence of infectious diseases, thereby decreasing the need for antibiotics and limiting the emergence and spread of resistant strains. Vaccines such as those against Streptococcus pneumoniae and Haemophilus influenzae have already demonstrated their effectiveness in reducing antibiotic use and resistance. Additionally, the development of new vaccines targeting resistant pathogens is crucial for future AMR control. Vaccination has a profound impact on AMR by preventing infections, which reduces the need for antibiotics and consequently the selection pressure for resistant strains. Herd immunity further amplifies these benefits by protecting unvaccinated individuals within the population. Vaccines are less likely to induce resistance compared to antibiotics, making them a sustainable tool in the fight against AMR. The economic benefits of vaccination, including reduced healthcare costs and improved public health outcomes, also support their broader implementation. To maximize the potential of vaccines in combating AMR, several actions are necessary. Governments and health organizations must prioritize the development and distribution of vaccines, especially in low- and middle-income countries where the burden of AMR is often highest. Increased investment in vaccine research and development is essential to create new vaccines targeting resistant pathogens. Public health policies should also focus on improving vaccination coverage and integrating vaccination strategies into broader AMR control programs. Furthermore, international collaboration and robust surveillance systems are crucial to monitor the impact of vaccination on AMR and to adapt strategies as needed. By implementing these measures, we can harness the full potential of vaccines to reduce the global threat of antimicrobial resistance. Acknowledgments The author extends sincere gratitude to the two anonymous peer reviewers for their contributions to the manuscript review process. Conflict of Interest Disclosure The author affirms that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. References Alghamdi S., 2021, The role of vaccines in combating antimicrobial resistance (AMR) bacteria, Saudi J Biol Sci., 28(12): 7505-7510. https://doi.org/10.1016/j.sjbs.2021.08.054 PMid:34867055 PMCid:PMC8626314 Andrejko K., Ratnasiri B., Hausdorff W., Laxminarayan R., and Lewnard J., 2021, Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis, The Lancet. Microbe, 2(9): 450-460. https://doi.org/10.1016/S2666-5247(21)00064-1 PMid:34485957 Brazzoli M., Piccioli D., and Marchetti F., 2023, Challenges in development of vaccines directed toward antimicrobial resistant bacterial species, Human Vaccines and Immunotherapeutics, 19(2): 2228669. https://doi.org/10.1080/21645515.2023.2228669 PMid:37449650 PMCid:PMC10351463 Buchy P., Aşçıoğlu S., Buisson Y., Datta S., Nissen M., Tambyah P., and Vong S., 2019, Impact of vaccines on antimicrobial resistance, Int J Infect Dis., 90: 188-196. https://doi.org/10.1016/j.ijid.2019.10.005 PMid:31622674
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==